Cupid Limited, a leading manufacturer of condoms and healthcare products in India, continues to strengthen its presence in both domestic and international markets. With a strong export portfolio, consistent revenue growth, and focus on quality products, the company has attracted significant investor interest.
Analysts are closely monitoring its performance as it capitalizes on increasing demand in the healthcare segment. The Cupid share price target for 2026, 2027, 2028, 2029, and 2030 reflects optimism about steady growth, improved margins, and expanding market share over the coming years.
Cupid Share Price Target 2026
Cupid Limited, a well-known player in the personal healthcare and wellness segment, continues to attract investor interest due to its strong product portfolio and growing presence in domestic and international markets.
The company’s focus on quality manufacturing, exports, and steady demand for its products supports long-term growth prospects.
Based on current business trends and industry outlook, the Cupid share price target for 2026 is expected to be in the range of ₹460 to ₹480. Sustained revenue growth, improving margins, and expansion into new markets could further support upside potential. However, investors should also consider market volatility and execution risks while evaluating long-term investments.
Cupid Share Price Target 2026 Table
| Year | Cupid Share Price Target 2026 |
| First Target 2026 | Rs 460 |
| Second Target 2026 | Rs 480 |
Cupid Share Price Target 2027
Cupid Limited is expected to remain in focus among investors due to its strong presence in the healthcare and wellness segment, especially in contraceptives and diagnostic products.
With rising awareness of family planning and increasing export opportunities, the company’s long-term growth outlook looks positive.
Based on current business expansion and improving financial stability, the Cupid share price target for 2027 is estimated to range between ₹520 (conservative target) and ₹540 (optimistic target). Continued government orders, global demand, and operational efficiency could further support steady upside potential for the stock over the coming years.
Cupid Share Price Target 2027 Table
| Year | Cupid Share Price Target 2027 |
| First Target 2027 | Rs 520 |
| Second Target 2027 | Rs 540 |
Cupid Share Price Target 2028
Cupid Limited is expected to remain in focus among long-term investors due to its strong presence in the healthcare and wellness segment, especially in male and female contraceptives.
The company’s steady export growth, improving margins, and healthy balance sheet support positive future prospects. If Cupid continues to expand its global footprint and maintain operational efficiency, the share price could see stable growth by 2028.
Based on current fundamentals and market trends, the Cupid share price target for 2028 is estimated to be in the range of ₹570 (conservative target) to ₹600 (optimistic target), depending on earnings growth and overall market conditions.
Cupid Share Price Target 2028 Table
| Year | Cupid Share Price Target 2028 |
| First Target 2028 | Rs 570 |
| Second Target 2028 | Rs 600 |
Cupid Share Price Target 2029
Cupid Limited is expected to remain in focus among long-term investors due to its strong presence in the healthcare and contraceptive manufacturing segment.
The company’s consistent export demand, improving margins, and focus on operational efficiency may support steady earnings growth over the coming years. By 2029, if Cupid continues to expand its global footprint and maintains healthy financial performance, the share price could see positive momentum.
Based on growth expectations and market conditions, the Cupid share price target for 2029 is estimated to be in the range of ₹630 to ₹650, making it an interesting stock to watch for long-term investors.
Cupid Share Price Target 2029 Table
| Year | Cupid Share Price Target 2029 |
| First Target 2029 | Rs 630 |
| Second Target 2029 | Rs 650 |
Cupid Share Price Target 2030
Cupid Limited is gradually strengthening its position in the healthcare and contraceptive products segment, supported by steady demand from both domestic and international markets.
The company’s focus on government tenders, export growth, and operational efficiency is expected to support long-term earnings visibility. As awareness around healthcare and family planning continues to rise, Cupid may benefit from consistent order inflows over the years.
Based on growth prospects and market conditions, the Cupid share price target for 2030 could range between ₹680 (lower target) and 700 (upper target), making it a stock to watch for long-term investors.
Cupid Share Price Target 2030 Table
| Year | Cupid Share Price Target 2030 |
| First Target 2030 | Rs 680 |
| Second Target 2030 | Rs 700 |
Cupid Share F.A.Q.
– What does Cupid Limited do?
Cupid Limited is an Indian company engaged in manufacturing and supplying male and female condoms, catering to both domestic and international markets.
– Is Cupid Share suitable for long-term investment?
Cupid Share is often considered for long-term investment due to its niche business, export focus, and steady demand in the healthcare segment.
– What factors affect Cupid Share price?
Cupid Share price is influenced by company earnings, export orders, government tenders, raw material costs, and overall market sentiment.
– Does Cupid Limited pay dividends?
Cupid Limited has a history of paying dividends, but payouts depend on profitability and management decisions in a given year.
– Is Cupid Share risky?
Like all small-cap stocks, Cupid Share carries risk due to business concentration and market volatility, so investors should assess carefully before investing.
Conclusion
Cupid Limited is well-positioned to benefit from the growing healthcare and personal protection market in India and abroad. With strong fundamentals, expanding exports, and consistent performance, investors can expect gradual appreciation in share value. The Cupid share price target for 2026 to 2030 indicates potential long-term growth, making it a stock worth considering for those seeking exposure to the healthcare manufacturing sector.
Also read:-